Abstract. A change in the protein level of RCAN1 (DSCR1/ MCIP/Adapt78/CSP1) has been implicated in oxidative stressinduced cell death in neurons and in the pathogenesis of Alzheimer's disease. The pathogenic processes in neurodegenerative diseases are closely related to oxidative stress and the ubiquitin proteasome system (UPS). Therefore, we investigated whether oxidative stress induces a change in the protein level of RCAN1 through the UPS. H 2 O 2 induced ubiquitination of RCAN1 at the same concentrations as those causing a decrease in RCAN1 in HEK293T cells. ß-TrCP, the F-box protein component of SCF ubiquitin ligase, interacted with RCAN1 in response to H 2 O 2 stimulation. Although FBW4, another F-box protein, interacted with RCAN1, its interaction was independent of H 2 O 2 stimulation. In vitro ubiquitination assay showed that SCF ß-TrCP but not SCF FBW4 increased ubiquitination of RCAN1, dependent on H 2 O 2 stimulation. In addition, knockdown of ß-TrCP by siRNA abolished the H 2 O 2 -induced decrease in RCAN1 in HEK293T cells. We further examined whether RCAN1 undergoes ubiquitination by H 2 O 2 in primary neurons, similarly to that in HEK293T cells. An H 2 O 2 -induced decrease in RCAN1 was exhibited also in hippocampal and cortical neurons. Ubiquitination of RCAN1 was induced by 500 μM H 2 O 2 , the concentration at which H 2 O 2 induced a decrease in RCAN1 in primary neurons. These results suggest that H 2 O 2 induces SCF ß-TrCP -mediated ubiquitination of RCAN1, leading to a decrease in the protein level of RCAN1.
Introduction
The physiological and pathological roles of regulators of calcineurin (RCAN) 1 (also known as DSCR1/MCIP/ Adapt78/CSP1) have been studied based on its gene locus, mRNA expression profile and protein function. The RCAN1 gene is located at 21q22.12, near the Down syndrome critical region on human chromosome 21, and consists of seven exons (1, 2) . The RCAN1 transcript is generated by alternative first exon splicing (exon 1-4), resulting in four different mRNA isoforms (2) . Two of these isoforms, RCAN1-1 and RCAN1-4, are mainly expressed and are detected in several tissues, including the brain and heart (2) (3) (4) .
RCAN1 interacts with important signaling molecules; calcineurin (Cn), integrin αvß3 and Raf-1 (5) (6) (7) (8) (9) . The function of RCAN1 in relation to Cn, among the interacting molecules, has been the most well defined. Cn is a serine/threonine phosphatase consisting of a catalytic A subunit (CnA) and a regulatory B subunit (10) (11) (12) (13) . RCAN1, through either the N-terminal or C-terminal region, binds to CnA and inhibits Cn activity in vitro (5, 7, 14) . Overexpression of RCAN1 in transgenic mice exhibits an inhibitory effect on Cn activity, as expected from in vitro studies (15, 16) . However, analysis of RCAN1 knockout mice by several groups demonstrated that RCAN1 led to facilitation and/or suppression of CnA activity under physiological and pathological conditions in each knockout mouse (17) (18) (19) (20) . The precise mechanism of CnA regulation by RCAN1 in vivo remains obscure.
Ubiquitin is a 76-amino acid polypeptide that is conjugated to lysine residues of the target protein (21, 22) . Conjugation of the poly-ubiquitin chain occurs through sequential steps catalyzed by a ubiquitin-activating enzyme (E1), ubiquitinconjugating enzyme (E2) and ubiquitin-protein ligase (E3) (23, 24) . The poly-ubiquitinated protein is recognized by 26S proteasome, followed by degradation (24, 25 (24, (26) (27) (28) . The ubiquitin-proteasome system (UPS) is implicated in the regulation of normal protein levels in response to cellular conditions and in the clearing of defective proteins. Impairment of the UPS causes deposition of ubiquitinated and aberrant proteins, resulting in cellular dysfunction. Studies indicate that impairment of the UPS is linked to the pathogenesis of neurodegenerative diseases, such as Alzheimer's (AD), Parkinson's and polyglutamine disease (29, 30) . Oxidative stress increases defective proteins and induces various cytotoxicity in cells, which is closely related to the pathogenic processes in neurodegenerative diseases (31, 32) . A change in RCAN1 protein level is detected in the brain of AD, and neurons in RCAN1 knockout mice exhibit resistance to cell death by oxidative stress (19, 33) . These findings suggest that a change in RCAN1 protein level may be required for a cellular response to oxidative stress. Recently, we and others demonstrated that a Saccharomyces cerevisiae ortholog of RCAN1 is ubiquitinated by a rise in intracellular Ca 2+ , and exogenously expressed human RCAN1-4 is ubiquitinated in normal culture conditions (34) (35) (36) . Moreover, oxidative stress induces a decrease in RCAN1-4 via an MG132-sensitive pathway in HeLa cells (37) . Taken together, these findings raise the possibility that oxidative stress may induce a ubiquitin-mediated decrease in the protein level of RCAN1. However, the precise mechanism of UPS regulation of the protein level of RCAN1 under oxidative stress remains unclear. Likewise, especially in neurons, whether RCAN1 is ubiquitinated under oxidative stress is unknown.
In the present study, we investigated whether RCAN1 undergoes ubiquitination in response to oxidative stress in HEK293T cells and primary neurons to gain further insight into the regulation of the RCAN1 protein level.
Materials and methods
Materials. PD150606 was purchased from Calbiochem (Nottingham, UK). MG132 was from Peptide Institute Inc. (Osaka, Japan). Anti-FLAG M2, anti-α-tubulin and anti-GAPDH antibodies were from Sigma (St. Louis, MO). Anti-HA (3F10 and 12CA5), anti-multi-ubiquitin, anti-lamin A/C and anti-neuronal class III ß-tubulin (TUJ1) antibodies were from Roche (Mannheim, Germany), MBL (Nagoya, Japan), Cell Signaling Technology (Beverly, MA) and Covance (Berkeley, CA), respectively.
Anti-RCAN1 antibodies. GST-human RCAN1-1 and its deletion mutant comprising amino acids (aa) 1-83 were expressed in Rosetta-gami 2 competent cells (Novagen, Madison, WI), and then purified recombinant GST proteins were used to immunize rabbits. Polyclonal antibodies were raised, and serum from the immunized rabbits was affinity purified commercially (Tanpaku Seisei Kogyo, Gunma, Japan). Anti-RCAN1.2 antibody was purified on a GST-RCAN1-1 affinity column. Anti-RCAN1.3 antibody was isolated through a two-step purification process: Antiserum was passed over a GST-RCAN1-1 (aa 1-83) affinity column, and the flow-through from the column was then purified on a GST-RCAN1-1 affinity column.
Cell culture. HEK293T cells were cultured in Dulbecco's modified Eagle's medium (DMEM) (Nissui Pharmaceutical Co., Tokyo, Japan) supplemented with 10% fetal bovine serum (Cansera International Inc., Ontario, Canada). In the case of non-transfection samples, cells were plated at 3x10 4 cells in 24-well plates and cultured for 24 h. Primary cultures of hippocampal and cortical neurons were performed as previously described with minor modification (38, 39) . Briefly, the hippocampus and cortex were dissected from the mouse brain on embryonic day 17 and incubated in dissociation solution [Earle's balanced salt solution containing 10 U papain (Sigma) and 1 mM KYN (Sigma)] at 37˚C for 20 min. After incubation, tissues were washed with neuronal medium [Minimum Essential Medium (Sigma) containing 10% horse serum (Sigma), N-2 supplement (1:100, Gibco, Grand Island, NY), 20 mM D-glucose, penicillin/streptomycin (1:500, Sigma), and 25 mM HEPES pH 7.5] and gently triturated 11 times by passing through a Pasteur pipette in 2 ml neuronal medium. The dissociated cells were passed through a 40-μm cell strainer (BD Falcon, San Diego, CA) and plated at 5x10 4 and 4x10 6 cells in poly-L-lysin (Sigma)-coated 48-well plates and 10-cm dishes, respectively. After plating, neurons were cultured for 7 days.
Plasmids. The coding regions of human RCAN1-1 (GenBank accession no. NM_004414) and FBW4 (GenBank accession no. AF281859) were amplified by PCR using human cDNA originating from the fetal brain and the liver (OriGene Technologies, Rockville, MD) as a template, respectively. That of human RCAN1-4 (GenBank accession no. NM_203418) was amplified by RT-PCR using total RNA from HEK293T cells as a template. Each PCR reaction used the following primer pairs: RCAN1-1, RCAN1-1f (5'-GGA TCCAAATGGAGGACGGCGTGGCCGG-3') and RCAN1r (5'-CCGCTCGAGTTCAGCTGAGGTGGATCGGCGTGT-3'); RCAN1-4, RCAN1-4f (5'-CGGGATCCAGATGCATT TTAGAAACTT-3') and RCAN1r, FBW4: FBW4f (5'-CGG AATTCTATGGCGGCGGCGGCCGGGGA-3') and FBW4r (5'-GCTCTAGATCATGGGTTTTGAAAATCCAGGACG TGG-3'). PCR products amplified using the primer pairs of RCAN1-1 and RCAN1-4 were inserted into BamHI and XhoI of pcDNA3 tagged with the FLAG epitope (pcDNA3-FLAG), and those amplified using the primer pair of FBW4 were inserted into BamHI and XbaI of pUHD-P2 tagged with the HA epitope (pUHD-P2-HA). The expression plasmids of HA-ß-TrCP1, HA-ß-TrCP2, myc-Rbx1 and FLAG-SKP1 were donated by Dr N. Watanabe (RIKEN) (40) . pcDNA3-myc-Cul1 and pcDNA3.1-HA-ubiquitin were donated by Dr K.I. Nakayama (Kyushu University) and Dr T. Chiba (Tokyo Metropolitan Institute of Medical Science), respectively (41, 42) .
Transfection of expression plasmid. HEK293T cells were plated at 3x10 4 cells and 1x10 5 cells in 24-well plates and 10-cm dishes, respectively, and incubated for 10 h. Cells were transfected with DNA using GeneJuice Transfection Reagent
(Novagen). The total amount of DNA was kept at 250 ng and 5 μg by the addition of empty plasmid to 24-well plates and 10-cm dishes, respectively. After 10 h, the transfection mixture was replaced with fresh culture medium and incubated for an additional 2 h.
Small interference RNA. Small interference RNA (siRNA) for ß-TrCP1/2 was custom synthesized by Dharmacon (Lafayette, CO). The target sequence of siRNA for ß-TrCP1/2 was described previously (40) . As a control, siCONTROL nontargeting siRNA #2 (Dharmacon) was used. Transfection of siRNA was performed by the reverse transfection method with Lipofectamine RNAiMax (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions. Briefly, siRNA was added to 100 μl OPTI-MEM I (Gibco) in 24-well plates at a final concentration of 10 nM, and then incubated with 0.75 μl Lipofectamine RNAiMax for 20 min at room temperature. HEK293T cells were seeded at a density of 5x10 4 cells into 24-well plates containing siRNA/transfection reagent complex. At 22 h after transfection, medium was replaced with fresh growth medium, and cells were incubated for another 2 h. In the case of the 6-cm dishes, it was performed with an 11-fold increase of all materials. We confirmed that ß-TrCP1/2 siRNA could inhibit >80% of the expression of ß-TrCP1 and ß-TrCP2 mRNAs in HEK293T cells under our experimental conditions.
Immunoprecipitation and re-immunoprecipitation.
After stimulation with the indicated reagents, cells were washed with ice-cold PBS and lysed with lysis buffer [20 mM Tris-HCl pH 8.0, 150 mM NaCl, 10 mM ß-glycerophosphate, 5 mM NaF, 1 mM Na 3 VO 4 , 0.5% Nonidet P-40 and protease inhibitor cocktail (Complete, Roche)]. Cell lysates were rotated at 4˚C for 6 h and centrifuged at 20,630 x g for 15 min. The supernatant was used for immunoprecipitation with anti-FLAG M2 antibody-conjugated agarose (anti-FLAG M2 affinity gel, Eastman Kodak Co., Rochester, NY), or anti-HA (12CA5) or anti-RCAN1.2 antibody precoupled to protein G agarose (Santa Cruz Biotechnology, Santa Cruz, CA), and then immunoprecipitates were washed four times with M2 buffer (43) . Re-immunoprecipitation (re-IP) was performed according to a previous method with minor modification (44) . Briefly, immunoprecipitates with anti-FLAG M2 affinity gel were suspended in 100 μl SDS buffer and boiled at 95˚C for 10 min. Samples were stored at room temperature to cool and then centrifuged at 20,630 x g for 10 min at 20˚C. The supernatant was diluted in 1.1 ml TX-100 buffer and subjected to immunoprecipitation with anti-FLAG M2 affinity gel. After washing in M2 buffer, immunoprecipitates were dissolved in Laemmli buffer and 20 mM Tris-HCl buffer (pH 7.4) prior to immunoblotting and in vitro ubiquitination assay, respectively.
Immunoblotting. Samples were subjected to SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA). Immunoblotting was performed with the indicated primary antibody and appropriate secondary antibody. Immunoreactive bands were visualized with ECL detection reagent (Amersham Life Science, Birmingham, UK) using a Lumivision Pro HSII image analyzer (Aisin Seiki, Aichi, Japan). Immunoblot images were saved as TIFF files, and pixel density was calculated for each band from TIFF files imported into YabGelImageX1.0.
In vitro ubiquitination assay and Western blotting with streptavidin-HRP. HEK293T cells were transfected with the expression plasmid of FLAG-RCAN1-1 or cotransfected with expression plasmids of SCF complex components (mycCul1, myc-Rbx, FLAG-Skp1 and either HA-ß-TrCP1 or HA-FBW4). Cells were stimulated with or without 5 mM H 2 O 2 for 10 min, and cell lysates were prepared for immunoprecipitation with anti-FLAG M2 or anti-HA (12CA5) antibody. Immunoprecipitates were washed four times with M2 buffer and once with 20 mM Tris-HCl buffer (pH 7.4), and then subjected to in vitro ubiquitination assay (Ubiquitinylation Kit, Biomol Research Laboratories, Plymouth Meeting, PA), according to the manufacturer's instructions with minor modification. Briefly, E1, E2 and the immunoprecipitated SCF complex were added to the immunoprecipitated RCAN1-1 in ubiquitinylation reaction buffer including biotinylated ubiquitin and the ATP regeneration system. The reaction mixture was incubated at 30˚C for 1.5 h and then terminated by washing with M2 buffer four times. Immunoprecipitates were dissolved in Laemmli (IP samples) or SDS buffer. Samples dissolved in SDS buffer were further used for re-immunoprecipitation (re-IP samples). IP and re-IP samples were subjected to SDS-PAGE and transferred to a PVDF membrane. The membrane was blocked with 1% BSA/0.1% Tween-20/TBS (TBS-T) for 1 h and washed three times with TBS-T for 10 min. Streptavidin-HRP (Vectastatin ABC Elite Kit, Vector Laboratories, Burlingame, CA) was prepared according to the manufacturer's instructions and diluted 1:30 with 1% BSA/ TBS-T. The membrane was incubated with diluted streptavidin-HRP for 2 h and then washed six times with TBS-T. Detection was carried out using ECL detection reagent.
Cellular fractionation. HEK293T cells were seeded on 6-cm dishes and transfected with siRNA. At 24 h after transfection, cells were stimulated with or without 5 mM H 2 O 2 for 30 min and washed with ice-cold PBS followed by addition of 100 μl hypotonic buffer (20 mM Tris-HCl pH 8.0, 10 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.2 mM sodium orthovanadate and 5 mM NaF). Cells were harvested and incubated on ice for 15 min with frequent vortexing. After incubation, cells were centrifuged at 1000 x g for 10 min. The pellet was resuspended in 100 μl extraction buffer I (ProteoExtract Subcellular Proteome Extraction Kit, Calbiochem) and rotated at 4˚C for 10 min followed by centrifugation at 1000 x g for 10 min. Each supernatant obtained by incubation with hypotonic buffer and extraction buffer I was collected together and centrifuged at 20,630 x g for 10 min. The resulting supernatant was used as the cytosolic fraction. The pellet obtained from extraction buffer I was resuspended in 100 μl extraction buffer II and rotated for 60 min followed by centrifugation at 6000 x g for 10 min. The pellet was resuspended in 50 μl extraction buffer III. Samples were rotated for 10 min and centrifuged at 6800 x g for 10 min. The supernatant was used as the nuclear fraction. Each protein fraction was added to four volumes of ice-cold acetone and incubated on ice for 15 min followed by centrifugation at 12,000 x g for 10 min. The pellet was dissolved in Laemmli buffer and subjected to immunoblotting. RCAN1-1 and RCAN1-4 . We examined whether the protein level of RCAN1 is changed by H 2 O 2 stimulation in HEK293T cells. As shown in Fig. 1A , H 2 O 2 induced a decrease in FLAG-RCAN1-1 and FLAG-RCAN1-4 at higher concentrations of H 2 O 2 (33±8 and 39±3% reduction of the FLAG-RCAN1-1 protein level at 1 and 5 mM H 2 O 2 , respectively; 22±6 and 23±6% reduction of FLAG-RCAN1-4 at 1 and 5 mM H 2 O 2 , respectively). As shown in Fig. 1B , endogenous RCAN1-1 was also decreased by H 2 O 2 stimulation with the same dose dependency as that for the decrease in FLAG-RCAN1-1 (37±3 and 42±4% reduction of the endogenous RCAN1-1 protein level at 1 and 5 mM H 2 O 2 , respectively).
Results

H 2 O 2 -induced decrease in
To assess whether or not the H 2 O 2 -induced decrease in RCAN1 is mediated by ubiquitination, we examined the occurrence of the covalent attachment of ubiquitin to RCAN1 in response to H 2 O 2 stimulation, using the method of re-immunoprecipitation (re-IP). Non-covalently bound proteins can be removed from re-IP samples by secondary immunoprecipitation using boiled first immunoprecipitates. As shown in Fig. 2A (Fig. 3B, right panel) . To further assess whether the SCF ß-TrCP1 -mediated high molecular weight smear specifically resulted from poly-ubiquitinated FLAG-RCAN1-1, immunoprecipitates of FLAG-RCAN1-1 were subjected to re-IP after the ubiquitination reaction with SCF ß-TrCP1 to exclude other interacting molecules. As shown in Fig. 3C Fig. 4A , ß-TrCP1/2 siRNA but not control siRNA abolished the H 2 O 2 -induced decrease in RCAN1-1. To further evaluate the cellular compartment in which RCAN1 is ubiquitinated by SCF ß-TrCP , we examined the effect of ß-TrCP1/2 siRNA on the protein level of RCAN1 in the subcellular fractions. As shown in Fig. 4B , ß-TrCP1/2 siRNA abolished the H 2 O 2 -induced decrease in RCAN1-1 in the cytosolic and nuclear fractions. In addition, immunoblotting using the nuclear fraction showed that endogenous RCAN1-4 was decreased by H 2 O 2 stimulation, which was abolished by ß-TrCP1/2 siRNA. These results suggest that SCF ß-TrCP mediated the H 2 O 2 -induced decrease in RCAN1-1 in the cytosol and nucleus and that of RCAN1-4 in the nucleus of HEK293T cells.
H 2 O 2 -induced ubiquitination of RCAN1-1 in primary neurons.
RCAN1 is expressed in the hippocampus and cerebral cortex of the human brain (4) . Neurons are sensitive to oxidative stress. Therefore, we investigated whether H 2 O 2 induces ubiquitination of RCAN1 in primary neurons, similarly to HEK293T cells expressing FLAG-RCAN1-1 or SCF complex components including HA-ß-TrCP1 or HA-FBW4 were stimulated with or without 5 mM H 2 O 2 for 10 min. Cell lysates were used for immunoprecipitation with anti-FLAG M2 or anti-HA (12CA5) antibody, and each immunoprecipitate was subjected to in vitro ubiquitination assay with biotinylated ubiquitin. After ubiquitination reaction, immunoprecipitates (IP) were terminated by adding Laemmli buffer. IP samples were subjected to Western blotting with streptavidin-HRP followed by reprobing with anti-FLAG M2 antibody. (C) HEK293T cells expressing FLAG-RCAN1-1 or SCF complex components including HA-ß-TrCP1 were stimulated with or without 5 mM H 2 O 2 for 10 min. Immunoprecipitates were prepared and used for in vitro ubiquitination assay. After the ubiquitination reaction, samples were boiled for 10 min at 95˚C and then used for reimmunoprecipitation with anti-FLAG M2 antibody (re-IP). The re-IP samples were subjected to Western blotting, as described in B.
that in HEK293T cells. As shown in Fig. 5A , H 2 O 2 induced a decrease in RCAN1 at higher concentrations for up to 2 h in hippocampal and cortical neurons (50-500 μM and 100-500 μM in hippocampal and cortical neurons, respectively). A previous study demonstrated that RCAN1 is cleaved through calpain, the Ca 2+ -activated protease, by exposure to 50 μM H 2 O 2 in cerebellar cortex neurons (19) . Then, we assessed whether or not the H 2 O 2 -induced decrease in RCAN1-1 was mediated by calpain in these neurons. As shown in Fig. 5B , 100 μM PD150606, an inhibitor of calpain I and II, prevented the decrease in RCAN1-1 by stimulation with 100 μM H 2 O 2 in hippocampal and cortical neurons. However, PD150606 failed to inhibit the decrease in RCAN1-1 at higher concentrations of H 2 O 2 (>200 and 500 μM in hippocampal and cortical neurons, respectively). Therefore, we investigated whether RCAN1 is ubiquitinated by stimulation with 100 and 500 μM The indicated siRNA was introduced into HEK293T cells on 6-cm dishes by reverse transfection method. After transfection, cells were stimulated with or without 5 mM H 2 O 2 for 30 min and then hypotonic buffer was added. Cells were harvested and divided into cytosolic and nuclear fractions. Each protein fraction was subjected to immunoblotting with anti-RCAN1.2 antibody, followed by reprobing with anti-GAPDH or anti-laminA/C antibody as an internal control for each fraction. The band intensities of RCAN1-1 in the cytosolic fraction and RCAN1-4 in the nuclear fraction were normalized against the corresponding internal control band intensity and presented on a bar graph, as described in A. in cortical neurons. As shown in Fig. 5C , the high molecular weight smear band was increased in RCAN1 immunoprecipitates from cortical neurons with stimulation by 500 μM H 2 O 2 compared to those of the control and stimulation by 100 μM H 2 O 2 . These results suggest that H 2 O 2 induced a decrease in RCAN1-1 via the ubiquitin pathway at the higher concentrations.
Discussion
RCAN1 was ubiquitinated by the same concentrations of H 2 O 2 as those for the H 2 O 2 -induced decrease in RCAN1, suggesting that the decrease in RCAN1 was caused by ubiquitination of RCAN1 (Figs. 1 and 2) . Then, to explore the mechanism of the H 2 O 2 -induced decrease in RCAN1 through the UPS, we investigated the E3 ubiquitin ligase for RCAN1 under H 2 O 2 stimulation. As shown in Fig. 3A , ß-TrCP1 and ß-TrCP2 interacted with RCAN1-1 in response to stimulation with H 2 O 2 . On the other hand, the interaction of FBW4 with RCAN1-1 was independent of H 2 O 2 stimulation. The results of the interaction between RCAN1-1 and F-box protein correlated with those of the in vitro ubiquitination assay. SCF ß-TrCP increased poly-ubiquitination of RCAN1-1 dependent on H 2 O 2 stimulation in both IP and re-IP samples (Fig. 3B, left panel and C) . However, SCF FBW4 -induced poly-ubiquitination of RCAN1-1 was independent of H 2 O 2 stimulation (Fig. 3B, right panel) . These results suggest that H 2 O 2 -induced ubiquitination of RCAN1-1 is mediated by SCF ß-TrCP . The experiments using ß-TrCP1/2 siRNA supported this suggestion. As shown in Fig. 4B , ß-TrCP1/2 siRNA abolished the H 2 O 2 -induced decrease in RCAN1-1 in the cytosol and nucleus and that of RCAN1-4 in the nucleus. Taken together, these results indicate that H 2 O 2 induced ubiquitination of RCAN1 via SCF ß-TrCP , resulting in a decrease in the protein level of RCAN1 in HEK293T cells.
It was reported that RCAN1-1 and RCAN1-4 have increased stability in the presence of MG132 and that overexpressed exogenous RCAN1-4 is ubiquitinated under normal culture conditions (35, 36, 45) . Our previous study demonstrated that the Saccharomyces cerevisiae ortholog of RCAN1 is ubiquitinated by SCF Cdc4 in response to a rise in intracellular Ca 2+ (34) . It may be possible that RCAN1-1 and RCAN1-4 are ubiquitinated by another E3 ubiquitin ligase, such as SCF FBW7 , human ortholog of SCF Cdc4 , and SCF FBW4 , under different conditions than oxidative stress. FBW4 is known as dactylin, and its gene is localized within the Split Hand-Split Foot malformation (SHFM) 3 critical region (46, 47) . Dactylindisrupted mice present malformed single digits and a lack of fore and hind paws in homozygotes. It is likely that RCAN1 could be involved in the developmental patterning of the limbs.
RCAN1-1 and RCAN1-4 exhibited different subcellular distributions. RCAN1-1 was largely distributed in the cytosol with little in the nucleus, and RCAN1-4 was distributed in the nucleus in HEK293T cells. A 24-kDa band corresponding to RCAN1-4 in whole cell lysates could not be detected with anti-RCAN1.2 antibody, but it was detected in nuclear protein extracts (Figs. 1B and 5B) . It may be difficult to detect RCAN1-4 in immunoblotting using whole cell lysates because of the low expression level of RCAN1-4 localized in the nucleus.
RCAN1 has been implicated in physiological and pathological responses in neurons. Thus, we investigated whether H 2 O 2 induces ubiquitination of RCAN1 in primary neurons. As shown in Fig. 5B , 500 μM H 2 O 2 induced a calpain-independent decrease in RCAN1-1 in neurons. In addition, the same concentration of H 2 O 2 also induced ubiquitination of RCAN1 (Fig. 5C) . These results suggest that a higher concentration of H 2 O 2 induces a decrease in RCAN1-1 through the ubiquitin pathway. Neurons in RCAN1 knockout mice exhibit more resistance to H 2 O 2 -induced cell death than wild-type neurons (19) . In this study, more than 1 mM and 500 μM H 2 O 2 finally led to cell death after 2 and 6 h of stimulation in HEK293T cells and primary neurons, respectively (data not shown). Ubiquitin-mediated degradation of RCAN1 may be required for the survival response to oxidative stress.
Based on our findings, oxidative stress induces a ubiquitinmediated decrease in RCAN1. However, RCAN1 is increased in the brains of Alzheimer's disease patients (AD), where oxidative stress is involved in the pathogenic process (4, 31, 32) . Previous findings have shown the deposition of ubiquitinated proteins by impairment of the UPS in neurodegenerative diseases including AD (29, 30) . We hypothesized that impairment of the UPS in AD might lead to the accumulation of ubiquitinated RCAN1 by oxidative stress, resulting in a change in Cn activity and resistance to damage by oxidative stress. To verify the hypothesis, further studies are needed.
In this study, we demonstrated that RCAN1 is a target of SCF ß-TrCP and that H 2 O 2 induces SCF ß-TrCP -mediated ubiquitination of RCAN1, leading to its decrease. These results suggest that degradation of RCAN1 by the ubiquitin pathway may be an important event in oxidative stressinduced cellular responses, including cell death.
